why choose us

First received: December 09, 2022

Clinical Trial: Renal Retention in High Grade Upper Tract Urothelial Cancer

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: High Grade Urothelial Carcinoma

Study Type: INTERVENTIONAL


Official Title: Renal Retention in High Grade Upper Tract Urothelial Cancer: A Phase II Trial of Enfortumab Vedotin and Pembrolizumab in Patients With Upper Tract Urothelial Cancer (UTUC) Who Are Not Candidates for,

Brief Summary: This trial will evaluate the use of combination pembrolizumab and enfortumab vedotin for patients with high grade non-metastatic (cN0/NxMx, no measurable regional lymph nodes, no metastases) upper tract urothelial cancer (UTUC), preferring to forego standard of care radical nephroureterectomy (RNU) surgery.Currently these patients would not be suitable candidates for neoadjuvant trials, as the patients intention is to forego surgery.The patients are also not candidates for metastatic trials, as the patients…

Read more